Speciality Drug House Bpl Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 2 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 Cr
- Revenue Growth %
- Profit Growth 9329.75%
- Ebitda 29955.65%
- Net Worth 541.88%
- Total Assets 20931.50%
About Speciality Drug House Bpl
Speciality Drug House Bpl Private Limited (SDHBPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 March 2022 (Two years and ten months 20 days old ). Its registered office is in Bhopal, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 Cr.
Rahul Thamman, Amit Rajpal, Varsha Malik, and Three other members serve as directors at the Company.
Company Details
-
Location
Bhopal, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51909MP2022PTC060031
-
Company No.
060031
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Mar 2022
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Speciality Drug House Bpl?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Thamman
|
Director | 23-Mar-2022 | Current |
|
Amit Rajpal
|
Director | 23-Mar-2022 | Current |
|
Varsha Malik
|
Director | 31-May-2024 | Current |
|
Amrit Rajpal
|
Director | 13-May-2024 | Current |
|
Priya Thamman
|
Director | 13-May-2024 | Current |
|
Hitesh Malik
|
Director | 23-Mar-2022 | Current |
Financial Performance of Speciality Drug House Bpl.
Speciality Drug House Bpl Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 9329.75% increase in profit. The company's net worth Soared by an impressive increase of 541.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Speciality Drug House Bpl?
Unlock access to Speciality Drug House Bpl's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹10.00 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Nov 2023 | Hdfc Bank Limited | ₹1.00 Cr | Open |
How Many Employees Work at Speciality Drug House Bpl?
Speciality Drug House Bpl has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Speciality Drug House Bpl, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Speciality Drug House Bpl's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.